Genemate - Lär dig mer om ärftlig cancer
Start Faq Blog Order Activate Log in Svenska

GeneMate® targeted services now available - select the test that suits your needs.

iCellate launches collaboration with football player Olivia Schough

25-04-2022

Stockholm, 21 April, 2022 – Cancer diagnostics company iCellate Medical AB announces collaboration with football star Olivia Schough. Olivia shares her story of hereditary cancer risk with the hope of helping others who are considering getting...

Project ELEVATE initiates clinical trial for development of novel cancer diagnostics

22-02-2022

February 10, 2022. Elthera AG, iCellate Medical AB, Targos Molecular Pathology GmbH and Prof. Dr. Susanne Sebens at the Institute of Experimental Cancer Research (IET) at the University of Kiel are proud to announce that the clinical trial for their...

Which genetic variants cause disease?

10-02-2022

While writing about genetic variants we use the terms benign, pathogenic, and variant of unknown significance (VUS). We’d like to take a moment to describe how genetic variants are classified as such.. . The more common genetic sequencing becom...

Calculate your risk

What is the likelihood that you carry a pathogenic variant?

12-01-2022

Calculate your risk for breast, ovarian, and prostate cancer. It can be hard to know if a hereditary cancer test is relevant for you. CanRisk is an online tool you can use to calculate th...

Mapping your family cancer history

The importance of family cancer history and how to map it

23-11-2021

Many families have a pretty good idea of who in the immediate family, if anyone, has been affected by what cancer type, and sometimes even as far out as aunts, uncles, and cousins. But as...

Hereditary stomach cancer

Stomach cancer is the fifth most common cancer in the world, and 10-20% is hereditary

08-07-2021

How common is stomach cancer?1. Gastric cancer (also called stomach cancer) has historically been the most common form of cancer in the world. During the past decades the frequency has decreased, and today gastric cancer is the fifth most common canc...

GeneMate® now a part of global rare disease database and resource Orphanet

Increased visibility of hereditary cancer risk can lead to increased opportunities for cancer prevention and early detection

01-07-2021

On June 17th, 2021, GeneMate® was accepted into the online database Orphanet, furthering iCellate’s goal of expanding access to genetic testing and cancer prevention.. In Orphanet’s words...

What to expect from your GeneMate® test

17-06-2021

In this blog post we will walk you through the various possible outcomes of your GeneMate® test.. A positive result means that a pathogenic variant was identified in one of the 41 genes that were analyzed. All genetic variants that are identified...

Behind the scenes of GeneMate®

10-06-2021

Ever wonder what happens to your saliva sample after returning it to iCellate's lab? Learn how your sample is handled and how iCellate determines your hereditary cancer risk.....

The importance of informing family members of a positive result

All first-degree relatives of a carrier have a 50% risk of themselves being a carrier

17-05-2021

Hereditary pathogenic variants (mutations) are relatively rare and most individuals that get tested with GeneMate® will test negative – meaning that they will not have an increased risk of...

Hereditary melanoma

Melanoma is the most rapidly increasing cancer in Sweden and 10-15% of all cases are hereditary

06-05-2021

How common is melanoma skin cancer?1. Melanoma skin cancer (referred to as melanoma from here on) is the sixth most common cancer type in Swedish men and the fifth most common in Swedish women. It is the most rapidly increasing cancer in Sweden, with...

Which genes does GeneMate® test and why?

Our clinically actionable selection of genes gives you a better shot at prevention.

03-05-2021

GeneMate® tests 41 genes, all of which play a role in regulating how cells grow, divide, or die. When cell regulation is not working correctly, the risk of uncontrolled cell growth and div...

Hereditary prostate cancer

1 in 5 Swedish men will be diagnosed with prostate cancer. Guidelines for the identification of hereditary prostate cancer are now expanded.

27-04-2021

How common is prostate cancer? 1. Every fifth man in Sweden will be diagnosed with prostate cancer during his lifetime, resulting in approximately 10 000 diagnoses each year. It is the most common type of cancer amongst Swedish men, but als...

Hereditary cancer: 97% of all carriers remain unidentified

Family history-based testing identifies some, misses many

23-04-2021

In the Swedish healthcare system, families must fulfill specific criteria to be offered genetic testing for hereditary cancer. One such criteria is the occurrence of several related cancer...

Polyposis syndromes

Polyposis' cause, associated cancer types, and risk-reducing measures

15-04-2021

In an earlier post we wrote about hereditary colorectal cancer syndromes, which can be divided into Lynch syndrome and polyposis syndromes. In this post we will tell you more about the different polyposis syndromes, their causes, associated cancer ty...

iCellate’s lab receives ISO 15189 certification by Swedac

iCellate is the only Swedish company that holds an ISO 15189 certification within cancer diagnostics.

13-04-2021

Stockholm, Sweden – April 12, 2021 - iCellate Medical AB, a Swedish cancer diagnostics company receives news of Swedac’s decision to certify according to ISO 15189:2012, Medical laboratori...

Hereditary ovarian cancer

15-20% of all ovarian cancer is hereditary

03-03-2021

How common is ovarian cancer?. Ovarian cancer is the seventh most common cancer in Swedish women and accounts 3% of all cancers in women1. The average lifetime risk of developing ovarian cancer is between 1–2%1,2. Ovarian cancer is difficult to...

Lynch Syndrome

Lynch syndrom is caused by hereditary pathogenic variants and increases the risk of several different cancer types

24-02-2021

In an earlier post we wrote about hereditary colorectal cancer syndromes, which can be divided into Lynch syndrome and polyposis syndromes. Lynch syndrome constitutes about 1-3% of all colorectal cancer and in this post, we will tell you more about t...

Things to consider prior to genetic testing

15-02-2021

There may be several reasons you wish to take a genetic test. In families with suspected hereditary cancer genetic testing is used to determine whether the cancer is caused by a pathogenic...

Hereditary breast cancer

15-20% of all breast cancer is hereditary

03-02-2021

How common is breast cancer?. More than one in ten Swedish women will be diagnosed with breast cancer during their liftetime, which makes breast cancer the most common type of cancer in Swedish women1. The majority of women are diagnosed between 60 a...

Hereditary colorectal cancer

One third of all colorectal cancer is hereditary

01-12-2020

How common is colorectal cancer?. About 7000 people get diagnosed with colorectal cancer in Sweden each year1, which makes it the third most common cancer in Sweden. A majority of 75% are diagnosed at 65 years of age or older. Colon cancer is equally...

Information

  • Start
  • Faq
  • Order
  • Activate
  • Log in
  • Icellate.se
  • Privacy Policy
  • Terms and Conditions
  • Terms of Purchase

Contact

iCellate Medical Genomics AB
Industrivägen 1
171 48 Solna
Sweden

Phone: 08 - 400 548 00
info@icellate.se
support@icellate.se

Follow us

Twitter Facebook Instagram Linkedin

iCellate - Genemate

© 2022 iCellate AB | All rights reserved.
GeneMate v.1.16.6